07/01/2025
3:40 PM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2025
3:49 PM | Dyne Therapeutics (Filer)
| Form 424B5 | |
06/30/2025
3:43 PM | Dyne Therapeutics (Filer)
| Form 424B5 | |
06/17/2025
6:04 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2025
3:30 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2025
8:37 PM | Dyne Therapeutics (Issuer)
Stehman-Breen Catherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
8:38 PM | Dyne Therapeutics (Issuer)
Incerti Carlo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
8:38 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
8:39 PM | Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
8:40 PM | Dyne Therapeutics (Issuer)
Lubner David Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2025
8:41 PM | Dyne Therapeutics (Issuer)
HURWITZ EDWARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for DYN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Dyne Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/15/2025
7:46 AM | Dyne Therapeutics (Subject)
Forbion Capital Fund IV Cooperatief U.A. (Filed by)
| Form SCHEDULE 13G/A | |
05/15/2025
7:17 AM | Dyne Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SCHEDULE 13G/A | |
05/14/2025
11:16 AM | Dyne Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
05/08/2025
6:25 AM | Dyne Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2025
6:35 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2025
6:34 AM | Dyne Therapeutics (Filer)
| Form DEF 14A | |
04/15/2025
6:35 AM | Dyne Therapeutics (Filer)
| Form DEFA14A | |
04/15/2025
6:38 AM | Dyne Therapeutics (Filer)
| Form ARS | |
04/01/2025
3:31 PM | Dyne Therapeutics (Issuer)
Lucera Erick (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2025
6:31 AM | Dyne Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/20/2025
3:08 PM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
3:07 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2025
3:08 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2025
3:09 PM | Cox John (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2025
3:10 PM | Dyne Therapeutics (Subject)
Kerr Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
6:25 AM | Dyne Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2025
6:35 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
6:20 AM | Dyne Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
11:22 AM | Dyne Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
8:00 AM | Dyne Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025
8:28 AM | Dyne Therapeutics (Subject)
FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/03/2025
4:07 PM | Dyne Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SCHEDULE 13G | |
01/29/2025
3:15 PM | Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
5:56 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
7:40 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
7:41 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
3:18 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024
3:19 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024
3:20 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2024
3:06 PM | Dyne Therapeutics (Subject)
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
This Cold War “Accident” Could Unleash New $100 Trillion AI Boom (Ad) Obscure Metal More Valuable than Gold and Bitcoin… COMBINED?
This strange "AI Metal" holds the key to the $100 trillion AI boom.
Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world.
And you won't believe what he uncovered. Click here to see the details because this could be the biggest tech story of this decade. |
11/18/2024
6:42 PM | Dyne Therapeutics (Issuer)
Incerti Carlo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
4:31 PM | Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
3:40 PM | Dyne Therapeutics (Subject)
Incerti Carlo (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
4:46 PM | Dyne Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
3:32 PM | Atlas Venture Fund XI, L.P. (Filed by)
Dyne Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
9:28 AM | Dyne Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G | |
11/14/2024
8:27 AM | Deep Track Capital, LP (Filed by)
Dyne Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
6:00 AM | Dyne Therapeutics (Subject)
Forbion Capital Fund IV Cooperatief U.A. (Filed by)
| Form SC 13G/A | |
11/14/2024
5:34 AM | Dyne Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G | |
11/12/2024
8:55 AM | Dyne Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
11/08/2024
4:31 PM | BlackRock, Inc. (Filed by)
Dyne Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024
9:20 AM | Dyne Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/22/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
2:24 PM | BlackRock, Inc. (Filed by)
Dyne Therapeutics (Subject)
| Form SC 13G/A | |
10/03/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/24/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
3:51 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
3:52 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2024
3:52 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:20 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:21 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:23 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:24 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:36 PM | Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:26 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:28 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:31 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:34 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:13 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:13 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:13 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:05 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
3:22 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
3:34 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
4:42 PM | Cox John (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
5:14 PM | Dyne Therapeutics (Issuer)
Kerr Douglas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/03/2024
5:16 PM | Dyne Therapeutics (Issuer)
Friedl-Naderer Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
5:20 PM | Dyne Therapeutics (Issuer)
Friedl-Naderer Johanna (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/03/2024
5:22 PM | Dyne Therapeutics (Issuer)
Kerr Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
6:16 AM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:05 PM | Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:26 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:26 PM | Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:27 PM | Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:27 PM | Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:28 PM | Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The End of Elon Musk…? (Ad) The End of Elon Musk? Don't make him laugh.
Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again.
And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again.
According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime. Click here to see why the "End of Elon" crowd is about to be wrong again. |
08/19/2024
3:13 PM | Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:08 PM | Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:10 PM | Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:11 PM | Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2024
3:12 PM | Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
4:15 PM | Dyne Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
4:05 PM | Dyne Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
3:37 PM | Dyne Therapeutics (Subject)
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
